|
Research Category
|
Principal Investigators
|
|
Juvenile Cardiomyopathy  Co-sponsored by the PWDCA
|
Meg Sleeper, VMD Paula Henthorn, PhD University of Pennsylvania
|
|
Objective: Finding the gene responsible for juvenile cardiomyopathy in the Portuguese Water Dog breed and develop a test to detect carriers.
|
|
|
|
Canine Hemangiosarcoma Co-sponsored by the PWDCA
|
Jaime F. Modiano, VMD, PhD University of Colorado*
|
|
Objective: The detection of Circulating Canine Hemangiosarcoma Cells using Multi-Parameter Flow Cytometry * Dr. Modiano is now at the University of Minnesota
|
|
|
|
Progressive Retinal Atrophy
|
Gustavo D. Aguirre, VMD, PhD Gregory M. Acland, BVSc University of Pennsylvania
|
|
Objective: Develop a mutant-based DNA test that identifies the actual mutant prcd gene that causes Progressive Retinal Atrophy in the Portuguese Water Dog.
|
|
|
|
THE FOLLOWING RESEARCH IS BEING CO-SPONSORED WITH THE AKC CANINE HEALTH FOUNDATION:
|
|
Grant #225 - Addison’s Disease
|
Anita M. Oberbauer, PhD University of California, Davis
|
|
Objective: The specific objectives of this grant are to expand our pedigree, phenotypic, and DNA databases for all possible Bearded Collies, Standard Poodles, Leonbergers, Portuguese Water Dogs and West Highland White Terriers as related to Addison's disease and to continue our genome scan of the DNA to identify a genetic marker linked to the single locus suggested by the pedigree analyses.
|
|
|
|
Grant #589A & B - Addison’s Disease
|
K. Gordon Lark, PhD University of Utah Elaine Ostrander, PhD National Human Genome Research Institute (NIH) (Government)
|
|
Objective: Identifying genes regulating Addison’s Disease in the Portuguese Water Dog
|
|
|
|
Grant #593A - Canine Hemangiosarcoma
|
Kerstin Lindblad-Toh, PhD Broad Institute at MA
|
|
Objective: Mapping genes associated with Canine Hemangiosarcoma
|
|
|
|
Grant #632 - Canine Lymphoma (completed)
|
W. C. Kisseberth, DVM, PhD Ohio State University
|
|
Objective: MicroRNAs and Canine Lymphoma
|
|
|
|
Grant #768 - Canine Lymphoma
|
Ted Valli, DVM University of Illinois
|
|
Objective: To enhance detection, diagnosis and treatment of lymphoma. Therefore altering cost of treatment according to the type of tumor (as in humans) and increase survival rate.
|
|
|
|
Grant #790 - Osteosarcoma, Transitional Cell Carcinoma & Melanoma
|
W. C. Kisseberth, DVM, PhD Ohio State University
|
|
Objective: The goals of this study are to identify important canine miRNAs that can be used to improve cancer diagnosis and treatment in the dog.
|
|
|
|
Grant #2226 - Addison’s Disease
|
A. M. Oberbauer, PhD University of California at Davis
|
|
Objective: Characterizing the inheritance of Addison’s Disease and linked DNA markers
|
|
|
|
Grant #2273 - Addison’s Disease
|
Marcus Rick, VetMed Michigan State University
|
|
Objective: Preclinical detection of hypoadrenocorticism (Addison’s Disease) in dogs.
|
|
|
|
Grant #2434 - Canine Hypothyroidism
|
Duncan Ferguson, DVM, PhD University of Georgia
|
|
Objective: Development of a more sensitive diagnostic assay for canine Hypothyroidism
|
|
|
|
THE FOLLOWING RESEARCH IS BEING CO-SPONSORED WITH THE MORRIS ANIMAL FOUNDATION:
|
|
#D08CA-402 Genetic Analysis of Hypoadrenocorticism in Nova Scotia Duck Tolling Retrievers
|
Dr. Angela M. Hughes Dr. Anita M. Oberbauer University of California-Davis
|
|
Objective: This study is to try and isolate the gene for Addison’s. Note: Even though this is in a different breed, any good results will help us greatly.
|
|
|
|
#D07CA-029 Pharmacokinetics and Pharmacodynamics of Hydroxyzine in Healthy Dogs
|
Dr. Thierry Olivry North Carolina State University
|
|
Objective: The goal of this study is to determine whether oral administration of the antihistamine hydroxyzine is absorbed into the dog's bloodstream and metabolized sufficiently to suppress allergic reactions. The results will help determine the optimal dose and frequency of this drug for treating atopic dermatitis in dogs.
|
|
|
|
#D07CA-034 MicroRNA Expression Profiling of Canine Osteosarcoma
|
Dr. W. C. Kisseberth Ohio State University
|
|
Objective: By studying miRNA expression in osteosarcoma, the investigators hope to identify new molecular targets for therapy that will lead to better treatment of this disease.
|
|
|
|
#D07CA-085 Pooled Association Mapping for Canine Hereditary Disorders
|
Dr. Gregory M. Acland Cornell University
|
|
Objective: To develop a system that will map genetic traits causing health problems.
|
|
|
|
#D06CA-050 Comparison of 2 ACTH Stimulation Tests in Determining Adrenal Function in Critically Ill Dogs
|
Dr. Linda G. Martin Washington State University
|
|
Objective: This study will compare the pituitary-adrenal function in critically ill dogs and use the information to determine the best way to diagnose this condition. An early detection test will help veterinarians to treat sick dogs more effectively.
|
|
|
|
#D06CA-065 Hemangiosarcoma and Melanoma
|
Jaime F. Modiano, VMD, PhD University of Minnesota
|
|
Objective: Researchers will investigate two proteins whose interactions seem to inhibit the growth of hemangiosarcoma and melanoma tumors and this study will test targeted therapies to significantly improve the lives of affected dogs.
|
|
|
|
#D04CA-108 Inflammatory Bowel Disease
|
Peter J. Felsburg, VMD, PhD University of Pennsylvania
|
|
Objective: Mechanisms of epithelial injury in canine Inflammatory Bowel Disease
|
|
|
|
#D03CA-071 Canine Hemangiosarcoma
|
Stuart C. Helfand, DVM University of Wisconsin
|
|
Objective: Receptor Tyrosine Activity in Canine Hemangiosarcoma
|
|
|
|
#D03CA-132 Relapsed Lymphoma
|
W. C. Kisseberth, DVM, PhD Ohio State University
|
|
Objective: Gene expression profiling of Relapsed Lymphoma in dogs
|
|
|
|
#99CA-001 Hip Dysplasia
|
Rory Todhunter, BVSc, PhD Cornell University
|
|
Objective: Mapping refinement of Quantitative Trait Loci for Canine Hip Dysplasia
|